Electrical Equipment & Parts
Compare Stocks
4 / 10Stock Comparison
NVX vs GPRE vs CLNE vs REX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Oil & Gas Refining & Marketing
Chemicals - Specialty
NVX vs GPRE vs CLNE vs REX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Chemicals - Specialty | Oil & Gas Refining & Marketing | Chemicals - Specialty |
| Market Cap | $150M | $1.15B | $507M | $1.60B |
| Revenue (TTM) | $13M | $1.94B | $439M | $651M |
| Net Income (TTM) | $-114M | $-15M | $-99M | $50M |
| Gross Margin | -255.3% | 1.8% | 11.7% | 12.7% |
| Operating Margin | -7.4% | 1.2% | 7.4% | 8.6% |
| Forward P/E | — | 46.6x | — | 62.8x |
| Total Debt | $70M | $508M | $99M | $21M |
| Cash & Equiv. | $43M | $182M | $158M | $196M |
NVX vs GPRE vs CLNE vs REX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 22 | May 26 | Return |
|---|---|---|---|
| Novonix Limited (NVX) | 100 | 4.7 | -95.3% |
| Green Plains Inc. (GPRE) | 100 | 50.3 | -49.7% |
| Clean Energy Fuels … (CLNE) | 100 | 31.8 | -68.2% |
| REX American Resour… (REX) | 100 | 309.3 | +209.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NVX vs GPRE vs CLNE vs REX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NVX is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 1.90
GPRE is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Lower P/E (46.6x vs 62.8x)
- +336.6% vs NVX's -39.1%
CLNE is the clearest fit if your priority is growth exposure.
- Rev growth 2.2%, EPS growth -173.0%, 3Y rev CAGR 0.4%
- 2.2% revenue growth vs NVX's -51.8%
REX carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 464.7% 10Y total return vs GPRE's 21.3%
- Lower volatility, beta 0.36, Low D/E 3.3%, current ratio 8.64x
- Beta 0.36, current ratio 8.64x
- 7.7% margin vs NVX's -8.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.2% revenue growth vs NVX's -51.8% | |
| Value | Lower P/E (46.6x vs 62.8x) | |
| Quality / Margins | 7.7% margin vs NVX's -8.8% | |
| Stability / Safety | Beta 0.36 vs NVX's 1.90, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +336.6% vs NVX's -39.1% | |
| Efficiency (ROA) | 6.7% ROA vs NVX's -47.6%, ROIC 11.4% vs -25.6% |
NVX vs GPRE vs CLNE vs REX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NVX vs GPRE vs CLNE vs REX — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
REX leads in 4 of 6 categories
GPRE leads 1 • NVX leads 1 • CLNE leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
REX leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GPRE is the larger business by revenue, generating $1.9B annually — 149.2x NVX's $13M. REX is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to NVX's -8.8%. On growth, CLNE holds the edge at +13.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $13M | $1.9B | $439M | $651M |
| EBITDAEarnings before interest/tax | -$86M | $122M | $62M | $67M |
| Net IncomeAfter-tax profit | -$114M | -$15M | -$99M | $50M |
| Free Cash FlowCash after capex | -$120M | $90M | $19M | $18M |
| Gross MarginGross profit ÷ Revenue | -2.6% | +1.8% | +11.7% | +12.7% |
| Operating MarginEBIT ÷ Revenue | -7.4% | +1.2% | +7.4% | +8.6% |
| Net MarginNet income ÷ Revenue | -8.8% | -0.8% | -22.7% | +7.7% |
| FCF MarginFCF ÷ Revenue | -9.2% | +4.7% | +4.3% | +2.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | -25.9% | +13.3% | +0.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +62.9% | +134.2% | +90.0% | +2.9% |
Valuation Metrics
GPRE leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, REX's 16.6x EV/EBITDA is more attractive than GPRE's 103.8x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $150M | $1.1B | $507M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $178M | $1.5B | $448M | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | -1.17x | -9.14x | -2.29x | 29.50x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 46.62x | — | 62.81x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.55x |
| EV / EBITDAEnterprise value multiple | — | 103.82x | 94.64x | 16.60x |
| Price / SalesMarket cap ÷ Revenue | 25.70x | 0.55x | 1.19x | 2.50x |
| Price / BookPrice ÷ Book value/share | 0.63x | 1.44x | 0.90x | 2.67x |
| Price / FCFMarket cap ÷ FCF | — | 17.84x | 8.47x | — |
Profitability & Efficiency
REX leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
REX delivers a 7.7% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-82 for NVX. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to GPRE's 0.66x. On the Piotroski fundamental quality scale (0–9), CLNE scores 5/9 vs NVX's 1/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -81.6% | -2.0% | -17.2% | +7.7% |
| ROA (TTM)Return on assets | -47.6% | -1.0% | -9.2% | +6.7% |
| ROICReturn on invested capital | -25.6% | -5.2% | -9.4% | +11.4% |
| ROCEReturn on capital employed | -23.7% | -6.2% | -9.4% | +10.1% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.51x | 0.66x | 0.18x | 0.03x |
| Net DebtTotal debt minus cash | $28M | $326M | -$59M | -$175M |
| Cash & Equiv.Liquid assets | $43M | $182M | $158M | $196M |
| Total DebtShort + long-term debt | $70M | $508M | $99M | $21M |
| Interest CoverageEBIT ÷ Interest expense | -15.52x | -0.08x | -1.07x | — |
Total Returns (Dividends Reinvested)
REX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REX five years ago would be worth $34,996 today (with dividends reinvested), compared to $315 for NVX. Over the past 12 months, GPRE leads with a +336.6% total return vs NVX's -39.1%. The 3-year compound annual growth rate (CAGR) favors REX at 50.8% vs NVX's -36.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -35.8% | +60.1% | +6.9% | +50.2% |
| 1-Year ReturnPast 12 months | -39.1% | +336.6% | +44.4% | +147.6% |
| 3-Year ReturnCumulative with dividends | -74.2% | -46.8% | -46.3% | +243.1% |
| 5-Year ReturnCumulative with dividends | -96.9% | -48.5% | -73.8% | +250.0% |
| 10-Year ReturnCumulative with dividends | -96.9% | +21.3% | -26.9% | +464.7% |
| CAGR (3Y)Annualised 3-year return | -36.3% | -19.0% | -18.7% | +50.8% |
Risk & Volatility
REX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
REX is the less volatile stock with a 0.36 beta — it tends to amplify market swings less than NVX's 1.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. REX currently trades 91.2% from its 52-week high vs NVX's 18.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.90x | 1.22x | 1.19x | 0.36x |
| 52-Week HighHighest price in past year | $3.86 | $18.94 | $3.11 | $53.36 |
| 52-Week LowLowest price in past year | $0.61 | $3.39 | $1.56 | $19.44 |
| % of 52W HighCurrent price vs 52-week peak | +18.1% | +86.9% | +74.3% | +91.2% |
| RSI (14)Momentum oscillator 0–100 | 47.5 | 54.3 | 44.6 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 354K | 1.5M | 1.3M | 204K |
Analyst Outlook
NVX leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: GPRE as "Buy", CLNE as "Buy", REX as "Buy". Consensus price targets imply 51.5% upside for CLNE (target: $4) vs -16.2% for GPRE (target: $14).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $13.80 | $3.50 | $60.00 |
| # AnalystsCovering analysts | — | 20 | 22 | 3 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.6% | +1.6% | +0.9% |
REX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GPRE leads in 1 (Valuation Metrics).
NVX vs GPRE vs CLNE vs REX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NVX or GPRE or CLNE or REX a better buy right now?
For growth investors, Clean Energy Fuels Corp.
(CLNE) is the stronger pick with 2. 2% revenue growth year-over-year, versus -51. 8% for Novonix Limited (NVX). REX American Resources Corporation (REX) offers the better valuation at 29. 5x trailing P/E (62. 8x forward), making it the more compelling value choice. Analysts rate Green Plains Inc. (GPRE) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NVX or GPRE or CLNE or REX?
On forward P/E, Green Plains Inc.
is actually cheaper at 46. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — NVX or GPRE or CLNE or REX?
Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +250.
0%, compared to -96. 9% for Novonix Limited (NVX). Over 10 years, the gap is even starker: REX returned +464. 7% versus NVX's -96. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NVX or GPRE or CLNE or REX?
By beta (market sensitivity over 5 years), REX American Resources Corporation (REX) is the lower-risk stock at 0.
36β versus Novonix Limited's 1. 90β — meaning NVX is approximately 423% more volatile than REX relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 66% for Green Plains Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NVX or GPRE or CLNE or REX?
By revenue growth (latest reported year), Clean Energy Fuels Corp.
(CLNE) is pulling ahead at 2. 2% versus -51. 8% for Novonix Limited (NVX). On earnings-per-share growth, the picture is similar: REX American Resources Corporation grew EPS -4. 9% year-over-year, compared to -173. 0% for Clean Energy Fuels Corp.. Over a 3-year CAGR, CLNE leads at 0. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NVX or GPRE or CLNE or REX?
REX American Resources Corporation (REX) is the more profitable company, earning 9.
1% net margin versus -1278. 0% for Novonix Limited — meaning it keeps 9. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REX leads at 10. 0% versus -880. 0% for NVX. At the gross margin level — before operating expenses — NVX leads at 69. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NVX or GPRE or CLNE or REX more undervalued right now?
On forward earnings alone, Green Plains Inc.
(GPRE) trades at 46. 6x forward P/E versus 62. 8x for REX American Resources Corporation — 16. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLNE: 51. 5% to $3. 50.
08Which pays a better dividend — NVX or GPRE or CLNE or REX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is NVX or GPRE or CLNE or REX better for a retirement portfolio?
For long-horizon retirement investors, REX American Resources Corporation (REX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
36), +464. 7% 10Y return). Novonix Limited (NVX) carries a higher beta of 1. 90 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (REX: +464. 7%, NVX: -96. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NVX and GPRE and CLNE and REX?
These companies operate in different sectors (NVX (Industrials) and GPRE (Basic Materials) and CLNE (Energy) and REX (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.